mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.004 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.004 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.005 |